Geertrui Vanhove - 10 Oct 2022 Form 4 Insider Report for Surrozen, Inc./DE (SRZN)

Role
Chief Medical Officer
Signature
/s/Sheela Mohan-Peterson, Attorney-in-Fact for Geertrui Vanhove
Issuer symbol
SRZN
Transactions as of
10 Oct 2022
Net transactions value
$0
Form type
4
Filing time
13 Oct 2022, 06:02:59 UTC
Previous filing
03 Mar 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRZN Option (right to buy) Disposed to Issuer -24,587 -100% 0 10 Oct 2022 Common Stock 24,587 $10.77 Direct F1, F2
transaction SRZN Option (right to buy) Disposed to Issuer -10,427 -100% 0 10 Oct 2022 Common Stock 10,427 $10.25 Direct F3, F4
transaction SRZN Option (right to buy) Disposed to Issuer -26,220 -100% 0 10 Oct 2022 Common Stock 26,220 $10.25 Direct F3, F4
transaction SRZN Option (right to buy) Disposed to Issuer -1,760 -100% 0 10 Oct 2022 Common Stock 1,760 $10.77 Direct F1, F2
transaction SRZN Option (right to buy) Award +26,220 26,220 10 Oct 2022 Common Stock 26,220 $2.16 Direct F3, F4
transaction SRZN Option (right to buy) Award +10,427 10,427 10 Oct 2022 Common Stock 10,427 $2.16 Direct F3, F4
transaction SRZN Option (right to buy) Award +24,587 24,587 10 Oct 2022 Common Stock 24,587 $2.16 Direct F1, F2
transaction SRZN Option (right to buy) Award +1,760 1,760 10 Oct 2022 Common Stock 1,760 $2.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price.
F2 The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
F3 The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price.
F4 Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years.